trending Market Intelligence /marketintelligence/en/news-insights/trending/k_fxluqe1xq43ezypdpz8a2 content esgSubNav
In This List

Sienna Cancer Diagnostics adds board director

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Sienna Cancer Diagnostics adds board director

Sienna Cancer Diagnostics Ltd. named Helen Fisher an independent nonexecutive director, effective March 28.

Fisher will also act as chair of the company's audit and risk committee. She was a partner at Deloitte and adviser to several life sciences and biotechnology companies, Sienna Cancer Diagnostics said in a news release.

Australia-based Sienna Cancer is a medical technology company developing and marketing innovative cancer related tests, with operations in the U.S. and Europe.